Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II single-arm study of BTT1023 in primary sclerosing cholangitis
2014-002393-37Phase 2Completed
- Sponsor
- University of Birmingham
- Start
- Nov 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of timolumab in Primary Sclerosing Cholangitis (PSC), sponsored by University of Birmingham. Primary endpoint: Response at Day 99. Started Nov 2014; status: completed.
02
Drugs
timolumab
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on 2014-002393-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002393-37.